Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

Eli Lilly market share drops, Novo Nordisk holds firm as generic weight-loss drugs flood India

The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters The market share of India’s most popular weight‑loss drugmaker, Eli Lilly, slipped in March, while rival Novo Nordisk held steady even as Indian generic drugmakers flooded the market with lower‑priced copies. Eli Lilly’s Indian market share in the GLP‑1 category of…

Read More
Anthropic weighs building its own AI chips: Reuters

Anthropic weighs building its own AI chips: Reuters

Artificial intelligence lab Anthropic is exploring the possibility of designing its own chips, three sources said, as the company and its rivals respond to a shortage of AI chips needed to power and develop more advanced AI systems. Samuel Boivin | Nurphoto | Getty Images Artificial intelligence lab Anthropic is exploring the possibility of designing its own chips, three sources said, as the…

Read More